[Predicting response to Iressa: unexpected mechanism]

Med Sci (Paris). 2004 Aug-Sep;20(8-9):750-1. doi: 10.1051/medsci/2004208-9750.
[Article in French]
No abstract available

Publication types

  • News

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Gefitinib
  • Humans
  • Neoplasms / drug therapy*
  • Patient Selection
  • Quinazolines / therapeutic use*
  • Remission Induction

Substances

  • Antineoplastic Agents
  • Quinazolines
  • Gefitinib